Abstract:We have reported that epoxyeicosatrienoic acids (EETs), the cytochrome P450 (CYP) epoxygenase metabolites of arachidonic acid (AA), are potent sarcolemmal ATP-sensitive K+ (K-ATP) channel activators. However, activation of cardiac and vascular K-ATP channels by endogenously produced EETs under physiological intracellular conditions has not been demonstrated and direct comparison of the mechanisms whereby EETs activate the K-ATP channels in cardiac myocytes versus vascular smooth muscle cells has not been made. In this study, we examined the effects of AA on K-ATP channels in freshly isolated cardiac myocytes from rats, wild-type (WT) and transgenic mice overexpressing CYP2J2 cDNA, and mesenteric arterial smooth muscle cells from rats. We also compared the activation of cardiac and vascular K-ATP channels by extracellularly and intracellularly applied 11,12-EET. We found that 1 mu m AA enhanced K-ATP channel activities in both cardiac and vascular smooth muscle cells, and the AA effects were inhibited by preincubation with CYP epoxygenase inhibitors. Baseline cardiac K-ATP current densities in CYP2J2 transgenic mice were 190% higher than those of WT mice, and both were reduced to similar levels by CYP epoxygenase inhibition. Western blot analysis showed that expression of Kir6.2 and SUR2A was similar between WT and CYP2J2 transgenic hearts. 11,12-EET (5 mu m) applied intracellularly enhanced the K-ATP currents by 850% in cardiac myocytes, but had no effect in vascular smooth muscle cells. In contrast, 11,12-EET (5 mu m) applied extracellularly increased K-ATP currents by 520% in mesenteric arterial smooth muscle cells, but by only 209% in cardiac myocytes. Preincubation with 100 mu m m-iodobenzylguanidine or 5 mu m myristoylated PKI amide did not alter the activation of cardiac K-ATP channels by 5 mu m 11,12-EET, but significantly inhibited activation of vascular K-ATP channels. Moreover, EET only enhanced the inward component of cardiac K-ATP currents, but activated both the inward and outward components of vascular K-ATP currents. Our results indicate that endogenously derived CYP metabolites of AA potently activate cardiac and vascular K-ATP channels. EETs regulate cardiac electrophysiology and vascular tone by K-ATP channel activation, albeit through different mechanisms: the cardiac K-ATP channels are directly activated by EETs, whereas activation of the vascular K-ATP channels by EETs is protein kinase A dependent.

Epoxyeicosatrienoic acids prevent cardiomyocytes against sepsis by A2AR-induced activation of PI3K and PPARγ

Epigallocatechin-3-gallate Ameliorates LPS-induced Inflammation by Inhibiting the Phosphorylation of Akt and ERK Signaling Molecules in Rat H9c2 Cells

Cardioprotection and mechanism of embelin in sepsis mice model

Electroacupuncture pre-treatment exerts a protective effect on LPS-induced cardiomyopathy in mice through the delivery of miR-381 via exosomes

Mitochondrial aldehyde dehydrogenase activity protects against lipopolysaccharide‑induced cardiac dysfunction in rats.

The Role of Epoxyeicosatrienoic Acids in Cardiac Remodeling

CYP2J2 Overexpression Increases EETs and Protects Against Angiotensin II-induced Abdominal Aortic Aneurysm in Mice

Endothelial α1-adrenergic receptor activation improves cardiac function in septic mice via PKC-ERK/p38MAPK signaling pathway

Soluble Epoxide Hydrolase Inhibitor Attenuates Lipopolysaccharide-Induced Acute Lung Injury and Improves Survival in Mice

CYP2J2-derived EETs Attenuated Ethanol-Induced Myocardial Dysfunction Through Inducing Autophagy and Reducing Apoptosis

Epoxyeicosatrienoic Acids Prevent Cardiac Dysfunction in Viral Myocarditis via Interferon Type I Signaling

Opposite Effects of Gene Deficiency and Pharmacological Inhibition of Soluble Epoxide Hydrolase on Cardiac Fibrosis

Epoxyeicosatrienoic Acids Prevent Cardiac Dysfunction in Viral Myocarditis via IFN-I Signaling

The Anti-inflammatory Mediator Resolvin E1 Protects Mice Against Lipopolysaccharide-Induced Heart Injury

Cardamonin Protects Against Lipopolysaccharide-Induced Myocardial Contractile Dysfunction in Mice Through Nrf2-regulated Mechanism

Cardiac and Vascular K-Atp Channels in Rats Are Activated by Endogenous Epoxyeicosatrienoic Acids Through Different Mechanisms

CYP2J2 and EETs protect against pulmonary arterial hypertension with lung ischemia-reperfusion injury in vivo and in vitro

Eets Alleviate Ox-Ldl-Induced Inflammation by Inhibiting Lox-1 Receptor Expression in Rat Pulmonary Arterial Endothelial Cells

Abstract 699: Mitochondrial Aldehyde Dehydrogenase (aldh-2) Protects Against Lipopolysaccharide-induced Myocardial Contractile Dysfunction by Suppression of ER Stress via Regulation of Autophagy

Cardiac and vascular K ATP channels in rats are activated by endogenous epoxyeicosatrienoic acids through different mechanisms: Activation of cardiac and vascular K ATP channels by EETs

Endothelial-derived exosomes induced by lipopolysaccharide alleviate rat cardiomyocytes injury and apoptosis